Neo Ivy Capital Management »

Vera Therapeutics shares owned by Neo Ivy Capital Management

Quarter-by-quarter ownership of Vera Therapeutics (VERA) shares owned by Neo Ivy Capital Management from 13F filings

Historical chart of Neo Ivy Capital Management investment in Vera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vera Therapeutics held by Neo Ivy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vera Therapeutics by Neo Ivy Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.1M 49k 42.91
2026-03-31 $490k 12k 40.23
2025-12-31 $1.3M 26k 50.64

More positions owned by Neo Ivy Capital Management

Vulcan Materials Company (VMC)
NVIDIA Corporation (NVDA)
Archer Daniels Midland Company (ADM)
Alkermes SHS (ALKS)
Palantir Techn-a Cl A (PLTR)
Lam Research (LRCX)
Micron Technology (MU)
Apple (AAPL)
Patterson-UTI Energy (PTEN)
Ultra Clean Holdings (UCTT)
Lyft Inc-a Cl A (LYFT)
Anthem (ELV)
Simmons First -a Cl A (SFNC)
International Paper Company (IP)
AGCO Corporation (AGCO)

View all positions for Neo Ivy Capital Management

Top funds holding Vera Therapeutics

BlackRock
venBio Select Advisor
T. Rowe Price Associates
Deep Track Capital
Deerfield Management Company
State Street Corporation
Kynam Capital Management
Sofinnova Ventures
FMR
Vanguard Capital Management
Eversept Partners
Logos Global Management
Integral Health Asset Management
Bellevue Group
Geode Capital Management

View all funds holding Vera Therapeutics